Osteoporosis Prevention With Low Dose Alendronate
NCT00463268
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
83
Enrollment
OTHER
Sponsor class
Conditions
Osteopenia
Interventions
DRUG:
alendronate
DIETARY_SUPPLEMENT:
Calcium/Vitamin D
DRUG:
placebo
Sponsor
University Hospital of Mont-Godinne